[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100514259":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":19,"locations":24,"responsibleParty":45,"collaborators":19,"id":48,"slug":49,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":19,"eligibilityCriteria":54,"healthyVolunteers":50,"sex":55,"minAge":56,"maxAge":19,"enrollmentInfo":57,"targetDuration":19,"studyType":60,"phases":61,"briefSummary":63,"conditions":64,"keywords":68,"overallStatus":27,"whyStopped":19,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":79},{"fullName":5,"class":6},"Mayo Clinic","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Breath Test Evaluation for SIBO","EXPERIMENTAL","Subjects with symptoms of gastroesophageal reflux disease (GERD) treated with a short course of proton pump inhibitors (PPI) clinically will undergo breath testing evaluating for small intestinal bacterial overgrowth (SIBO).",[13],"Other: Breath Testing",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":19},"Breath Testing","Subjects drink a small carbohydrate solution, and then provide a breath sample every 15 minutes for one hour, and then every 30 minutes for the next two hours",[9],null,[21],{"name":22,"affiliation":5,"role":23},"Andree Koop, MD","PRINCIPAL_INVESTIGATOR",[25],{"facility":26,"status":27,"city":28,"state":29,"zip":30,"country":31,"countryCode":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"Mayo Clinic Florida","RECRUITING","Jacksonville","Florida","32224","United States","US",{"type":34,"coordinates":35},"Point",[36,37],-81.65565,30.33218,{"lat":37,"lon":36},[40],{"name":41,"role":42,"phone":43,"phoneExt":19,"email":44},"Andree H Koop, MD","CONTACT","9049533970","koop.andree@mayo.edu",{"type":23,"investigatorFullName":46,"investigatorTitle":47,"investigatorAffiliation":5,"oldNameTitle":19,"oldOrganization":19},"Andree H. Koop","Principal Investigator","100514259","a-study-of-breath-testing-for-small-intestinal-bacterial-overgrowth-100514259",false,"NCT05976165","A Study of Breath Testing for Small Intestinal Bacterial Overgrowth","Breath Testing for Small Intestinal Bacterial Overgrowth in Patients Treated With Proton Pump Inhibitors","Inclusion criteria:\n\n* Predominant symptoms of gastroesophageal reflux disease including heartburn, regurgitation\n* Subjects must be able to give appropriate informed consent\n\nExclusion criteria:\n\n* Prior diagnosis of SIBO\n* Use of PPIs or H2R-anatagonstists in the prior 3 months\n* Major concomitant illness (renal, hepatic, rheumatologic or cardiovascular disease, or malignancy)\n* Antibiotic therapy within one month\n* Prior gastrointestinal surgery including esophageal, gastric, and small or large bowel surgery\n* Previously diagnosed irritable bowel syndrome or inflammatory bowel disease\n* Individuals who are pregnant or breast feeding\n* Patients with plans to become pregnant\n* Inability to take PPIs, including allergy\u002Fsensitivity","ALL","18 Years",{"count":58,"type":59},50,"ESTIMATED","INTERVENTIONAL",[62],"NA","Researchers hope to determine how often small intestinal bacterial overgrowth occurs after taking proton pump inhibitors.",[65,66,67],"Gastroesophageal Reflux","Regurgitation","Heartburn",[69],"Proton pump inhibitor","2026-02-10",{"date":72,"type":73},"2026-02-12","ACTUAL",{"date":75,"type":73},"2023-11-17",{"date":77,"type":59},"2027-01-31",{"name":5,"class":6},1]